Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients
Open Access
- 1 December 1990
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 536 (1-2) , 240-244
- https://doi.org/10.1016/0006-8993(90)90030-f
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- In vivo 31 P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementiaNeurology, 1989
- Down syndrome, Alzheimer's disease and the trisomy 16 mouseTrends in Neurosciences, 1988
- Neurochemical aspects of Alzheimer's disease: Involvement of membrane phospholipidsMetabolic Brain Disease, 1988
- Abnormal platelet membrane composition in Alzheimer's-type dementiaLife Sciences, 1987
- Age related decline in aluminum-activated human platelet adenylate cyclase: Post-receptor changes in cyclic AMP second messenger signal amplification in normal aging and dementia of the Alzheimer typeLife Sciences, 1986
- Lymphocyte concanavalin A capping: a similarity between Down's syndrome and early onset primary degenerative dementia.Journal of Neurology, Neurosurgery & Psychiatry, 1986
- INCREASED GLYCEROL-3-PHOSPHORYLCHOUNE IN POST-MORTEM ALZHEIMER'S BRAINThe Lancet, 1985
- Choline and Cholinergic NeuronsScience, 1983
- NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIESBrain, 1976
- A novel pathway for phosphatidylcholine catabolism in rat brain homogenatesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975